GC-rich DNA binding sites

GC-rich DNA binding sites are specific regulatory sequences, often containing the GC-box motif (5'-GGGGCGGGG-3'), located in the promoter and enhancer regions of numerous genes. These sites are the primary targets for zinc-finger transcription factors such as Sp1 and Egr-1, which are essential for the expression of genes involved in cell growth, differentiation, and survival. In the context of AP-1-regulated transcription, GC-rich elements in the promoters of the c-jun and c-fos genes are critical for the production of the AP-1 complex itself. Therapeutic agents like Mithramycin A (Plicamycin) and its analogues bind to the minor groove of these GC-rich sequences with high affinity, displacing transcription factors and inhibiting the transcription of downstream target genes. This mechanism is particularly relevant in cancers like Ewing sarcoma and testicular cancer, where it can suppress oncogenic signaling and induce apoptosis. However, the clinical utility of drugs targeting GC-rich DNA is often limited by significant systemic toxicities, including hepatotoxicity and thrombocytopenia, due to the ubiquitous nature of these sites across the human genome.

Other names

GC-boxGC-rich elementsSp1 binding sitesMithramycin binding sitesPlicamycin binding sitesGC-rich DNA

Minor groove binding to GC-rich DNA sequences, leading to the competitive displacement of transcription factors (e.g., Sp1, Egr-1) and subsequent inhibition of gene transcription.